Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Inflammation × cytisine × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Smoking Cessation 1 Motor Activity 1 Lung Neoplasms 1 Inflammation 1

Interventions

semaglutide 1 cytisine 1 bupropion hydrochloride, naltrexone hydrochoride drug combination 1 Topiramate 1 Tirzepatide 1 Surgical Procedures, Operative 1 Spirometry 1 Radiotherapy 1 Qsymia 1 Phentermine 1 Naltrexone 1 Mindfulness 1 Liraglutide 1 Hematologic Tests 1 Glucagon-Like Peptide-1 Receptor 1 Diethylpropion 1 Diet Therapy 1 Bupropion 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03654105 2024-03-07

SMILE

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Active not recruiting

Inflammation, Lung Neoplasms, Motor Activity, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡